ResearcherTongji HospitalActive in the last 2 years

Lihong Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-1296-3237; OpenAlex author ID A5091118313. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2025: 1 paper

Papers 1

FAM111B and FANCD2, a dual expression signature, defines a distinct phenotype of pancreatic cancer. Last author DOI 10.1186/s12935-025-03819-6 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Fang Wei · 1 shared paper, 2025 · strength 0.30
- Paper FAM111B and FANCD2, a dual expression signature, defines a distinct phenotype of pancreatic cancer. DOI 10.1186/s12935-025-03819-6 ↗
Xianglin Yuan · 1 shared paper, 2025 · strength 0.30
- Paper FAM111B and FANCD2, a dual expression signature, defines a distinct phenotype of pancreatic cancer. DOI 10.1186/s12935-025-03819-6 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.